Review Article Volume 4 Issue 4
Cambridge University, UK
Correspondence: Vaughan Daniels Hepnar, EMEA Holmium Clinical Manager at Lumenis LTD, Lumenis LTD, Strickland House Independant, The Henley College, Gloucester CAT, Cambridge University Teddington, Greater London, UK, Tel 1 -954 439 8764
Received: January 13, 2017 | Published: April 10, 2017
Citation: Perelman J, Hepnar VD (2017) Men’s Power-Pressure Wave Erectile Regeneration-Therapy: an Early Assessment. Urol Nephrol Open Access J 4(4): 00136. DOI: 10.15406/unoaj.2017.04.00136
Introduction: Low intensity extracorporeal shockwave therapy for erectile dysfunction (LISWT) has been well researched as a treatment for Erectile Dysfunction (ED) and used as a first line treatment in many parts of the world as a viable alternative to oral, on-demand, phosphodiesterase type 5 inhibitors (PDE5i). Though effective, these drugs have limitations and are associated with significant non-compliance, side effects and do not reverse the underlying pathology [1-3]. Non-invasive low intensity shockwave therapy (LISWT) has been shown to significantly improve erectile function in men previously PDE5i dependent.
Materials and Methods: Vaughan Medical LLC based in Fort Lauderdale, USA purchased the STORZ Medical D-ACTOR 100 to treat patients with ED with the C-15 Ceramic Grey Tip at 15 Hertz and 2.6 Bar with 500 pulses per 1.5 cm on top of the shaft and 1,000 pulses right side then 1,000 left side just below the shaft on the pelvis/corporal bundle. Each patient had 6 treatments either two treatments per week for three weeks or one treatment per week for six weeks randomized by patient preference and/or to fit in with clinic schedules [4-7].
Results: Men’s PoWER Therapy using the STORZ Medical D-ACTOR 100 (LISWT) has shown in this early experience to be an effective treatment paradigm for erectile dysfunction. All patients completed the treatment regime and all gained an improvement in their SHIM score with an average improvement from Moderate ED to Mild-Moderate after 6 treatments. It appears from this early experience that the optimal treatment regime is six (6) treatments at two treatments per week for three weeks [8-11]. The same energy settings were used for all patients of 15 Hertz and 2.6 bars with 500 pulses per 1.5 cm on top of the shaft and 1,000 pulses right side then 1,000 left sides just below the shaft on the pelvis/corporal bundle.
Conclusion: The early experience of LISWT has shown an improvement in the sexual function of patients and a treatment regime of two treatments per week for three weeks appears optimal but further research is required [12-15].
Keywords:Men’s PoWER Therapy;Lowintensity extracorporeal shockwave therapy; Erectile Dysfunction
LISWT: Low Intensity Extracorporeal Shockwave Therapy for Erectile Dysfunction; ED: Erectile Dysfunction; PDE5i: Phosphodiesterase Type 5 Inhibitors; PDE5: Phosphodiesterase Type 5
Used in medicine since the 1980s, shockwave therapy involves the aiming of shockwaves-energy waves that travel faster than the speed of sound-toward treatment areas from outside the body. The approach is sometimes used to break up kidney stones and treat conditions like joint pain, bursitis, and tendinitis. More recently, scientists have examined its use in the treatment of ED, with encouraging results. Low-intensity extracorporeal shock wave therapy (LIESWT) to the penis has recently emerged as a new and promising modality in the treatment of erectile dysfunction (ED). Shock waves are acoustic waves that generate a pressure impulse and that carry energy when propagating through a medium [16,17]. The degree of focus can be modulated noninvasively, resulting in variable concentration of energy at a desired location. When shock waves are applied to an organ, the focused waves interact with the targeted deep tissues and act as transient micromechanical forces that initiate several biological changes [18].
This initial study focused on the first initial experience of the LISWT procedure known under the name Men’s PoWER Therapy with 22 patients with ED who did not have success with phosphodiesterase type 5 (PDE5) inhibitors or required spontaneous erections. Many patients found the medications are not suitable and some they don’t respond to them. Some participants also had vascular risk factors that could contribute to ED, such as diabetes, high lipid levels, high blood pressure, and possible coronary artery disease. For three to six weeks, the men participated in either twice weekly or once weekly PoWER Therapy sessions lasting just a few minutes [19-21]. Six sessions in all with the STORZ Medical D-ACTOR 100 D with the C-15 Ceramic Grey Tip at 15 Hertz and 2.6 Bar with 500 pulses per 1.5 cm on top of the shaft and 1,000 pulses right side then 1,000 left side just below the shaft on the pelvis/corporal bundle with topical Lidocaine offered and used at patient discretion. At each appointment, shockwaves were applied to the penis and the perineum (the area between the anus and the scrotum). The men completed a SHIM score at start and post last treatment [22,23].
Before treatment, and again at last treatment point, the men’s erectile function was assessed using the SHIM score measurements, which is often used in medical studies of ED. The patients were all treated by one of two practitioners. All twenty two (22) of the men (average age: 57.78 years) completed the treatment regime so we calculated the results based on data from this group. We found that 95% of the men had improved erections based on the SHIM Score measurement tool at last treatment. None of the men had side effects from treatment. The men’s age and the length of time with ED did not affect the results. We acknowledge several limitations, including the lack of a placebo group and to date no long term follow up [23-25].
We stress the need for further research to determine long term benefit and how many LISWT sessions would be most effective and over what period of time (treatment regime) and which men are the best candidates for this therapy. The patients (Table 1) were selected randomly into two groups by patient preference and/or to fit in with clinic schedules between two treatments per week and one treatment session per week. In the two treatment sessions a week group an 8 point average increase in SHIM score was noted from 9.17 to 17.17 average with an average age of 63.33 years (Table 2) where in the one treatment per week group an average increase on 3 point score was noted from 7.5 to 10.5 with an average age of 55.69 years (Table 3). It is worth noting that the ED score was severe in the one treatment per week group and only moderate in the two treatment sessions a week group (Figure 1-3) [26-31].
The IIEF-5 Questionnaire (SHIM) |
|||||
Over the past 6 month: |
Very low 1 |
Low-2 |
Moderate 3 |
High 4 |
Very High 5 |
2. When you had erections with sexual stimulation, how often were your erections hard enough for penetration? |
Almost never or never 1 |
A few times (much less than half the time) 2 |
Sometimes (about half the time) 3 |
Most times (much more than half the time) 4 |
Almost always or always 5 |
3. During sexual intercourse, how often were you able to maintain your erection after you had penetrated your partner? |
Almost never of never 1 |
A few times (much less than half the time) 2 |
Sometimes (about half the time) 3 |
Most times (much more than half the time) 4 |
Almost always or always 5 |
4. During sexual intercourse, how difficult was it to maintain your erection to completion of intercourse? |
Extremely difficult 1 |
Very difficult 2 |
Difficult 3 |
Slightly difficult 4 |
Not difficult 5 |
5. When you attempted sexual intercourse, how often was it satisfactory for you? |
Almost never or never 1 |
A few times (much less than half the time) 2 |
Sometimes (about half the time) 3 |
Most times (much more than half the time) 4 |
Almost always or always 5 |
Figure 3: SHIM Score Form.
Total score: _____ 1-7: Severe ED 8-11: Moderate ED 12-16: Mild-moderate ED 17-21: Mild ED 22-25: No ED
N = 22 |
Median |
Range |
Age Years |
40.5 |
( 39 – 80 ) |
IIEF-5 Questionnaire (SHIM) at start |
7.05 |
3 - 20 |
IIEF-5 Questionnaire (SHIM) after last treatment |
10.5 |
5 - 22 |
Table 1: Patient group-an early assessment.
N = 6 |
Median |
Range |
Age Years |
63.33 |
( 53 – 75) |
IIEF-5 Questionnaire (SHIM) at start |
9.17 |
5 - 18 |
IIEF-5 Questionnaire (SHIM) after last treatment |
17.17 |
6 - 22 |
Table 2: Two treatments per week cohort.
N = 16 |
Median |
Range |
Age Years |
55.69 |
( 39 – 80 ) |
IIEF-5 Questionnaire (SHIM) at start |
7.05 |
3 - 20 |
IIEF-5 Questionnaire (SHIM) after last treatment |
10.5 |
5 - 22 |
Table 3: One treatment per week cohort.
©2017 Perelman, et al. This is an open access article distributed under the terms of the, which permits unrestricted use, distribution, and build upon your work non-commercially.